Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers

Abstract

Background: MicroRNAs (miRNAs) are non-uniformly distributed in genomes and ~30% of the miRNAs in the human genome are clustered. In this study we have focused on the imprinted miRNA cluster miR-379/miR-656 on 14q32.31 (hereafter C14) to test their coordinated function. We have analyzed expression profile of >1000 human miRNAs in >1400 samples representing seven different human tissue types obtained from cancer patients along with matched and unmatched controls. Results: We found 68% of the miRNAs in this cluster to be significantly downregulated in Glioblastoma Multiforme (GBM), 61% downregulated in Kidney Renal Clear Cell Carcinoma (KIRC), 46% in Breast Invasive Carcinoma (BRCA) and 14% in Ovarian Serous cystadenocarcinoma (OV). On a genome-wide scale C14 miRNAs accounted for 12-30 % of the total downregulated miRNAs in different cancers. Pathway enrichment for the predicted targets of C14 miRNA was significant for cancer pathways, especially Glioma (p<3.77x10^-6, FDR<0.005). The observed downregulation was confirmed in GBM patients by real-time PCR, where 79% of C14 miRNAs (34/43) showed downregulation. In GBM samples, hypermethylation at C14 locus (p<0.003) and downregulation of MEF2, a crucial transcription factor for the cluster was observed which likely contribute to the observed downregulation of the entire miRNA cluster. Conclusion: We provide compelling evidence that the entire C14 miRNA cluster is a tumor suppressor locus involved in multiple cancers, especially in GBM, and points toward a general mechanism of coordinated function for clustered miRNAs.